Both in Biotechnology
INmune Bio vs Caribou Biosciences
Over the past year INMB returned −22.7% and CRBU returned −79.5%; their daily moves had a correlation of 0.20.
INMB −22.7% CRBU −79.5%Growth of $1, one year, split-adjusted
| Metric | INMB | CRBU |
|---|---|---|
| Price | $1.33 | $0.4444 |
| Market cap | $41.2M | $47.6M |
| Today | +0.76% | −3.27% |
| 1 month | −28.9% | −60.8% |
| 6 months | −12.5% | −77.2% |
| Year to date | −14.7% | −72.1% |
| 1 year | −26.1% | −81.7% |
| Revenue growth (YoY) | — | −43.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1619.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.7× |
| Net cash | $18.4M | $112.3M |
| Dividend yield | — | — |
| Volatility (60d) | 65.4% | 146.2% |
| Short % of float | 11.7% | 13.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).